This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Nanyang Technological University, Singapore Health Services Pte Ltd. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2018
Title: Innovations of Freddy Boey in Ocular Drug Delivery
Introduction
Freddy Boey is a prominent inventor based in Singapore, known for his contributions to the field of ocular drug delivery. His innovative work has led to the development of a stable liposomal formulation that enhances the effectiveness of drug delivery to the eyes. This formulation is particularly significant for treating various ocular disorders.
Latest Patents
Freddy Boey holds a patent for "Stable liposomal formulations for ocular drug delivery." This patent describes a stable liposomal formulation that includes at least one lipid bilayer containing phosphatidylcholine and a prostaglandin F encapsulated within the liposome. The formulation is designed to improve the treatment of ocular disorders, showcasing his commitment to advancing medical technology.
Career Highlights
Throughout his career, Freddy Boey has worked with esteemed institutions such as Nanyang Technological University and Singapore Health Services Pte Ltd. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to significant advancements in ocular drug delivery.
Collaborations
Freddy has collaborated with notable professionals, including Subramanian Venkatraman and Jayaganesh V Natarajan. These partnerships have further enriched his research and development efforts, leading to innovative solutions in the medical field.
Conclusion
Freddy Boey's work in developing stable liposomal formulations for ocular drug delivery represents a significant advancement in medical technology. His contributions continue to impact the treatment of ocular disorders, highlighting the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile